de Souza, M.G.F.; de Jesus Guedes, F.N.; Tebaldi, M.L.; do Nascimento Alencar, É.; Amaral-Machado, L.; do Egito, E.S.T.; de Barros, A.L.B.; Soares, D.C.F.
Ferri–Liposomes: Preformulation and Selective Cytotoxicity against A549 Lung Cancer Cells. Pharmaceutics 2021, 13, 712.
https://doi.org/10.3390/pharmaceutics13050712
AMA Style
de Souza MGF, de Jesus Guedes FN, Tebaldi ML, do Nascimento Alencar É, Amaral-Machado L, do Egito EST, de Barros ALB, Soares DCF.
Ferri–Liposomes: Preformulation and Selective Cytotoxicity against A549 Lung Cancer Cells. Pharmaceutics. 2021; 13(5):712.
https://doi.org/10.3390/pharmaceutics13050712
Chicago/Turabian Style
de Souza, Marina Guedes Fonseca, Fabrícia Nunes de Jesus Guedes, Marli Luiza Tebaldi, Éverton do Nascimento Alencar, Lucas Amaral-Machado, Eryvaldo Sócrates Tabosa do Egito, André Luis Branco de Barros, and Daniel Crístian Ferreira Soares.
2021. "Ferri–Liposomes: Preformulation and Selective Cytotoxicity against A549 Lung Cancer Cells" Pharmaceutics 13, no. 5: 712.
https://doi.org/10.3390/pharmaceutics13050712
APA Style
de Souza, M. G. F., de Jesus Guedes, F. N., Tebaldi, M. L., do Nascimento Alencar, É., Amaral-Machado, L., do Egito, E. S. T., de Barros, A. L. B., & Soares, D. C. F.
(2021). Ferri–Liposomes: Preformulation and Selective Cytotoxicity against A549 Lung Cancer Cells. Pharmaceutics, 13(5), 712.
https://doi.org/10.3390/pharmaceutics13050712